If these effects prove to be temporally robust, unlike those seen with DEX and other glucocorticoids in RT-induced lung inflammatory mediator responses, pneumonitis and fibrosis in rodent models [44,82,83], then this approach may be especially relevant in the treatment of breast cancer with RT since adipocytes are the major source of ATX in the breast. Here, ENPP2 is linked to breast cancer.